Department of Bioengineering, University of Pennsylvania, 210 South 33rd St., Philadelphia, PA 19104-6321, USA.
Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L992-1002. doi: 10.1152/ajplung.00175.2011. Epub 2012 Jan 27.
Alveolar epithelial cells (AECs) maintain integrity of the blood-gas barrier with actin-anchored intercellular tight junctions. Stretched type I-like AECs undergo magnitude- and frequency-dependent actin cytoskeletal remodeling into perijunctional actin rings. On the basis of published studies in human pulmonary artery endothelial cells (HPAECs), we hypothesize that RhoA activity, Rho kinase (ROCK) activity, and phosphorylation of myosin light chain II (MLC2) increase in stretched type I-like AECs in a manner that is dependent on stretch magnitude, and that RhoA, ROCK, or MLC2 activity inhibition will attenuate stretch-induced actin remodeling and preserve barrier properties. Primary type I-like AEC monolayers were stretched biaxially to create a change in surface area (ΔSA) of 12%, 25%, or 37% in a cyclic manner at 0.25 Hz for up to 60 min or left unstretched. Type I-like AECs were also treated with Rho pathway inhibitors (ML-7, Y-27632, or blebbistatin) and stained for F-actin or treated with the myosin phosphatase inhibitor calyculin-A and quantified for monolayer permeability. Counter to our hypothesis, ROCK activity and MLC2 phosphorylation decreased in type I-like AECs stretched to 25% and 37% ΔSA and did not change in monolayers stretched to 12% ΔSA. Furthermore, RhoA activity decreased in type I-like AECs stretched to 37% ΔSA. In contrast, MLC2 phosphorylation in HPAECs increased when HPAECs were stretched to 12% ΔSA but then decreased when they were stretched to 37% ΔSA, similar to type I-like AECs. Perijunctional actin rings were observed in unstretched type I-like AECs treated with the Rho pathway inhibitor blebbistatin. Myosin phosphatase inhibition increased MLC2 phosphorylation in stretched type I-like AECs but had no effect on monolayer permeability. In summary, stretch alters RhoA activity, ROCK activity, and MLC2 phosphorylation in a manner dependent on stretch magnitude and cell type.
肺泡上皮细胞 (AEC) 通过与肌动蛋白锚定的细胞间紧密连接来维持血-气屏障的完整性。拉伸的 I 型样 AEC 经历幅度和频率依赖性的肌动蛋白细胞骨架重塑为周细胞肌动蛋白环。基于已发表的人肺动脉内皮细胞 (HPAEC) 的研究,我们假设在拉伸的 I 型样 AEC 中,RhoA 活性、Rho 激酶 (ROCK) 活性和肌球蛋白轻链 II (MLC2) 的磷酸化增加的方式依赖于拉伸幅度,并且 RhoA、ROCK 或 MLC2 活性抑制将减弱拉伸诱导的肌动蛋白重塑并维持屏障特性。将 I 型样 AEC 单层以 0.25 Hz 的频率周期性地双向拉伸,以将表面积变化 (ΔSA) 增加 12%、25%或 37%,持续 60 分钟或不拉伸。还将 I 型样 AEC 用 Rho 通路抑制剂 (ML-7、Y-27632 或 blebbistatin) 处理并用 F-肌动蛋白染色或用肌球蛋白磷酸酶抑制剂 calyculin-A 处理并量化单层通透性。与我们的假设相反,在拉伸至 25%和 37%ΔSA 的 I 型样 AEC 中,ROCK 活性和 MLC2 磷酸化降低,而在拉伸至 12%ΔSA 的单层中没有变化。此外,在拉伸至 37%ΔSA 的 I 型样 AEC 中,RhoA 活性降低。相比之下,当 HPAEC 拉伸至 12%ΔSA 时,HPAEC 中的 MLC2 磷酸化增加,但当拉伸至 37%ΔSA 时,MLC2 磷酸化降低,类似于 I 型样 AEC。在用 Rho 通路抑制剂 blebbistatin 处理的未拉伸的 I 型样 AEC 中观察到周细胞肌动蛋白环。肌球蛋白磷酸酶抑制增加了拉伸的 I 型样 AEC 中的 MLC2 磷酸化,但对单层通透性没有影响。总之,拉伸以依赖于拉伸幅度和细胞类型的方式改变 RhoA 活性、ROCK 活性和 MLC2 磷酸化。